Health Trials

FL Lymphoma

2

Review clinical trials related to FL Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2003 in patients with different types of lymphoma

Participants needed: 180
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: ModeX Therapeutics, An OPKO Health CompanyUpdated: May 4, 2026Locations: 2
Eligibility criteria

Participant must be ≥ 18 years of age. [+8]

Known or suspected history of hemophagocytic lymphohistiocytosis (HLH). [+8]

Read more
Status: Recruiting

Evaluate the Safety and Clinical Activity of HH2853

This is an open-label, multicenter, first-in-human phase I/II study which is composed of 3 parts: phase I dose escalation, phase I dose extension and phase II. HH2853 will be administered orally on a continuous BID schedule on a continuous 28-day treatment cycle.

Participants needed: 254
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Haihe Biopharma Co., Ltd.Updated: Jan 30, 2026Locations: 25
Eligibility criteria

Provided signed written informed consent prior to initiation of any study-relate... [+8]

Any cancer-directed therapy within 28 days or five half-lives prior to first dos... [+11]

Read more